x

Search for a clinical trial

* (*) mandatory field

12 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

FRANCE

ILE-DE-FRANCE
PARIS

Funded by an IRDiRC memberPhase I/II clinical trial of haematopoietic stem cell gene therapy for the Wiskott-Aldrich Syndrome - FR
Hôpital Necker-Enfants Malades
Développement normal et pathologique du système immunitaire

FRANCE

ILE-DE-FRANCE
PARIS

Funded by an IRDiRC memberPhase I/II clinical trial of haematopoietic stem cell gene therapy for the Wiskott-Aldrich Syndrome - FR
Hôpital Necker-Enfants Malades
Département de Biothérapie - Unité d'Hémaphérèse Thérapeutique

GERMANY

Bayern
MÜNCHEN

Gene therapy of Wiskott Aldrich Syndrome (Phase I-II) - DE
Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital
Care-for-Rare Center (CRCHauner)

ITALY

LOMBARDIA
MILANO

Ongoing trial
Funded by an IRDiRC memberTIGET-WAS - A Phase I/II Clinical Trial of Hematopoietic Stem Cell Gene Therapy for the Wiskott-Aldrich Syndrome
Istituto San Raffaele Telethon per la Terapia Genica - TIGET
Istituto San Raffaele Telethon per la Terapia Genica

ITALY

LOMBARDIA
PAVIA

Eltrombopag per le trombocitopenie ereditarie
Fondazione IRCCS Policlinico San Matteo
Clinica Medica III

UNITED KINGDOM

Greater London
LONDON

UNITED STATES

Pennsylvania
PHILADELPHIA

Multinational clinical trial(s)